Skip to main content
. Author manuscript; available in PMC: 2017 Jan 12.
Published in final edited form as: Vaccine. 2015 Dec 2;34(3):313–319. doi: 10.1016/j.vaccine.2015.11.056

Table 2.

Demographics for Enrolled Subjects Receiving at Least One Dose

CMV gB + MF59 (N=195) Placebo (N=207) All (N=402) P-value
N Subjects in Safety Population 195 207 402
Age at Vaccination(years) 0.1890 [1]
 Mean (SD) 14.7 (1.64) 14.5 (1.60) 14.6 (1.62)
 Median 15.0 15.0 15.0
 Min, Max 12, 18 12, 17 12, 18
 Q1 : Q3 13.0 : 16.0 13.0 : 16.0 13.0 : 16.0
Age Category at Vaccination, n (%) 0.5860 [2]
 12–15 years old 124 (64) 137 (66) 261 (65)
 > 15 years old 71 (36) 70 (34) 141 (35)
Ethnic origin, n (%) 0.5956 [2]
 Hispanic or Latino 22 (11) 20 (10) 42 (10)
 Not Hispanic or Latino 173 (89) 187 (90) 360 (90)
Race, n (%) 0.2494 [2]
 Black 77 (39) 88 (43) 165 (41)
 Caucasian 103 (53) 95 (46) 198 (49)
 Other 15 (8) 24 (12) 39 (10)
[1]

P-value is from an analysis of variance with treatment as an effect in the model.

[2]

P-value is from a Chi-square test.